| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.22M | 35.20M | 30.43M | 25.03M | 33.06M | 43.66M |
| Gross Profit | 15.42M | 18.41M | 15.97M | 13.23M | 22.09M | 34.52M |
| EBITDA | 6.96M | 8.99M | -4.68M | 4.49M | 25.70M | 36.86M |
| Net Income | 3.36M | 3.46M | -7.58M | 2.84M | 26.10M | 34.46M |
Balance Sheet | ||||||
| Total Assets | 201.89M | 203.49M | 204.91M | 218.19M | 214.80M | 192.44M |
| Cash, Cash Equivalents and Short-Term Investments | 34.47M | 40.09M | 46.94M | 37.83M | 61.28M | 57.21M |
| Total Debt | 1.15M | 758.00K | 702.00K | 907.00K | 452.00K | 473.00K |
| Total Liabilities | 14.77M | 15.58M | 15.67M | 15.27M | 14.21M | 16.42M |
| Stockholders Equity | 187.11M | 187.91M | 189.24M | 202.92M | 200.59M | 176.02M |
Cash Flow | ||||||
| Free Cash Flow | 6.41M | 8.59M | 6.97M | 3.48M | 13.51M | 5.61M |
| Operating Cash Flow | 6.65M | 8.72M | 7.08M | 3.55M | 13.59M | 5.66M |
| Investing Cash Flow | -13.68M | -9.31M | 9.85M | -18.16M | -9.25M | 25.42M |
| Financing Cash Flow | -4.72M | -6.25M | -7.55M | -3.89M | -2.78M | -558.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £226.43M | 2.03 | 30.90% | 3.21% | 165.25% | 95.32% | |
76 Outperform | £185.89M | 5.84 | 12.06% | 8.15% | 1.29% | 11.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £116.90M | 21.20 | 1.79% | 3.29% | -9.37% | ― | |
64 Neutral | £144.64M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
62 Neutral | £143.88M | 11.98 | 17.51% | 17.93% | -16.53% | -44.15% | |
50 Neutral | £463.80M | 8.09 | 7.16% | ― | ― | 33.10% |